Cellebrite DI Ltd. (CLBT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.51B |
| Enterprise Value | 4.4B |
| P/E Ratio | 46.94 |
| PEG Ratio | 0.54 |
| Price/Sales Ratio | 5.36 |
| Price/Book Ratio | 5.08 |
| Enterprise/Revenue | 5.13 |
| Enterprise/EBITDA | 23.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.11 |
| Return On Assets | 0.06 |
| Return On Equity | 0.12 |
| Revenue | 475.68M |
| Revenue/Share | 2.08 |
| Gross Profit | 400.5M |
| EBITDA | 103.07M |
| Net Income | 78.33M |
| Diluted EPS | 0.31 |
| Total Cash | 442.53M |
| Total Cash/Share | 1.79 |
| Total Debt | 23.23M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 1.6 |
| Book Value Per Share | 2.17 |
| 52-Week Change | -31.41 |
| 52-Week High | 19.98 |
| 52-Week Low | 9.58 |
| Moving Average 50 Days | 14.25 |
| Moving Average 200 Days | 14.96 |
| Average Volume | 2.76M |
| Shares Outstanding | 249.44M |
| % Held by Institutions | 50.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |